SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (1238)12/17/1997 10:47:00 AM
From: Harry D. Kramer  Read Replies (1) | Respond to of 2205
 
To all,
the FDA approved Chiron's Regranex for diabetic foot ulcers today. Chiron and J&J will now have a headstart over ATIS of approximately 4-8 months. Probably not enough, but we will see.

Harry



To: Rick Strange who wrote (1238)12/18/1997 10:12:00 PM
From: Jake  Read Replies (1) | Respond to of 2205
 
Are you looking this up on a web site?

Jake,
The FDA has not yet published the information in the Federal Register. By law the information
must be published 15 days prior to the meeting or by January 14th., in this case. Usually, the
notice is published about a month prior to the meeting.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News